| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.00039 | 1 |